JANX vs AAPL: Which Stock is Better?
Side-by-side comparison of Janux Therapeutics Inc and Apple Inc in 2026
JANX
Janux Therapeutics Inc
$14.90
AAPL
Apple Inc
$258.44
Key Metrics Comparison
| Metric | JANX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $908.22M | N/A | JANX |
| P/E Ratio | N/A | 33.01 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | 21.8% | 0.2% | JANX |
| Gross Margin | -1159.0% | 47.3% | AAPL |
Analyze JANX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JANX or AAPL a better investment?
Comparing JANX and AAPL: Janux Therapeutics Inc has a market cap of $908.22M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JANX and AAPL?
JANX (Janux Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JANX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JANX or AAPL?
JANX has higher revenue growth at 21.8% vs 0.2% for AAPL.
Which company is more profitable: JANX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -1159.0% for JANX.
Which is the larger company: JANX or AAPL?
Janux Therapeutics Inc (JANX) is larger with a market cap of $908.22M compared to N/A for AAPL.
Should I buy JANX or AAPL in 2026?
Both JANX and AAPL have investment merit. JANX trades at $14.90 while AAPL trades at $258.44. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JANX and AAPL stock?
Key differences: Market Cap ($908.22M vs N/A), P/E Ratio (N/A vs 33.0x), Revenue Growth (21.8% vs 0.2%), Gross Margin (-1159.0% vs 47.3%).